The PE Ratio as of December 2025 (TTM) for Newbury Pharmaceuticals AB (publ) (NEWBRY.ST) is -1.65

According to Newbury Pharmaceuticals AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -1.65. This represents a change of 5.10% compared to the average of -1.57 of the last 4 quarters.

Newbury Pharmaceuticals AB (publ) (NEWBRY.ST) Historical PE Ratio (quarterly & annually)

How has NEWBRY.ST PE Ratio performed in the past?

The mean historical PE Ratio of Newbury Pharmaceuticals AB (publ) over the last ten years is -12.51. The current -1.65 PE Ratio has changed 1.22% with respect to the historical average. Over the past ten years (40 quarters), NEWBRY.ST's PE Ratio was at its highest in in the August 2024 quarter at 11.52. The PE Ratio was at its lowest in in the November 2020 quarter at -257.17.

Newbury Pharmaceuticals AB (publ) (NEWBRY.ST) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Newbury Pharmaceuticals AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Newbury Pharmaceuticals AB (publ) (NEWBRY.ST) Average PE Ratio

How has NEWBRY.ST PE Ratio performed in the past?

The current PE Ratio of Newbury Pharmaceuticals AB (publ) (NEWBRY.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Newbury Pharmaceuticals AB (publ) (NEWBRY.ST) PE Ratio vs. Peers

How is NEWBRY.ST’s PE Ratio compared to its peers?

Newbury Pharmaceuticals AB (publ)’s PE Ratio is greater than Ortivus AB (publ) (-2.33), greater than OncoZenge AB (publ) (-8.75), greater than Simris Alg AB (publ) (-1.84), less than Lipigon Pharmaceuticals AB (publ) (-0.20), greater than AcouSort AB (publ) (-4.05), less than ExpreS2ion Biotech Holding AB (publ) (-0.96), greater than ODI Pharma AB (-5.18), greater than ScandiDos AB (publ) (-48.71), less than Scandinavian Real Heart AB (Publ) (-0.80),

Build a custom stock screener for Newbury Pharmaceuticals AB (publ) (NEWBRY.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Newbury Pharmaceuticals AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Newbury Pharmaceuticals AB (publ) (NEWBRY.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Newbury Pharmaceuticals AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.